埃莫丁对慢性阻塞性肺病肺炎和肠道微生物的影响
1Respiratory Department of the First Affiliated Hospital of Henan University of Chinese Medicine, Zhengzhou, 450000, People's Republic of China.
Journal of inflammation research
|July 29, 2025
概括
在慢性阻塞性肺病 (COPD) 的小鼠中,埃莫丁治疗显著降低了肺炎,而布他诺酸被确定为关键的肠道微生物代谢物. 来自接受治疗的小鼠的便移植进一步改善了炎症,这表明COPD治疗中的肠肺轴连接.
科学领域:
- 药理学 药理学是指药理学的学科.
- 免疫学 免疫学 免疫学
- 微生物学 微生物学
背景情况:
- 慢性阻塞性肺病 (COPD) 构成了全球重大健康负担.
- 埃莫丁是一种天然化合物,具有抗炎性质,但其在COPD治疗中的有效性仍未得到充分研究.
研究的目的:
- 在小鼠模型中研究emodin对COPD的治疗效果.
- 探索肠道微生物群和HMGB1-RAGE通路在emodin作用中的作用.
主要方法:
- 建立了COPD小鼠模型,并用emodin进行治疗.
- 评估了肺部病理,炎症标志物和HMGB1-RAGE表达.
- 分析了肠道微生物代谢物和便微生物群移植.
主要成果:
- 埃莫丁显著降低了COPD小鼠的肺炎和改善了肺组织病理.
- 丁酸作为以埃莫丁治疗小鼠肠道微生物群中的关键差异性代谢物出现.
- 从接受埃莫丁治疗的小鼠中移植便微生物群抑制了炎症反应,并降低了接受者COPD小鼠的HMGB1-RAGE通路的调节.
结论:
- 埃莫丁证明了对COPD的治疗潜力,可能通过调节肠道微生物群和HMGB1-RAGE炎症途径来调节.
- 这些发现凸显了肠肺轴作为COPD潜在的治疗点.
相关概念视频
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
3.1K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
3.1K
01:22Chronic Obstructive Pulmonary Disease
1.4K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
1.4K
01:25Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
2.9K
Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
2.9K
01:20Chronic Obstructive Pulmonary Disease-I: Introduction
2.9K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
2.9K
01:20COPD: Pathogenesis and Clinical Features
528
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
528
01:26COPD: Management Using Bronchodilators and Corticosteroids
314
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
314